Glyxambi 5 MILLIGRAM/1 TABLET, 25 MILLIGRAM/1 TABLET Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

glyxambi 5 milligram/1 tablet, 25 milligram/1 tablet

شركة مستودع الادوية العربي - the arab drug store p.s.c - linagliptin 5 milligram/1 tablet, empagliflozin 25 milligram/1 tablet - 5 milligram/1 tablet, 25 milligram/1 tablet

KONIX ® YODURO DE POVIDONA 10% SOLUCIÓN Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

konix ® yoduro de povidona 10% solución

turkuaz saglik hizmetleri medikal temizlik kimyasal ÜrÜnler sanayi ve ticaret a.s. - povidona - povidona....10 %

Entresto 24/26 New Zealand - English - Medsafe (Medicines Safety Authority)

entresto 24/26

novartis new zealand ltd - sacubitril/valsartan 50mg (as sodium hydrate complex, contains 24.3 mg sacubitril and 25.7 mg valsartan);  ;   - film coated tablet - 24.3 mg/25.7 mg - active: sacubitril/valsartan 50mg (as sodium hydrate complex, contains 24.3 mg sacubitril and 25.7 mg valsartan)     excipient: colloidal silicon dioxide crospovidone hyprolose basic coating premix, white basic coating premix, red basic coating premix, black magnesium stearate microcrystalline cellulose purified talc purified water - entresto is indicated in adult patients with chronic heart failure (nyha class ii-iv). benefits are most clearly evident in patients with left ventricular ejection fraction (lvef) below normal. lvef is a variable measure, so use clinical judgment in deciding whom to treat

ENTRESTO 24/26 sacubitril/valsartan (combined as a sodium salt hydrate complex) 24.3/25.7 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

entresto 24/26 sacubitril/valsartan (combined as a sodium salt hydrate complex) 24.3/25.7 mg film-coated tablet blister pack

novartis pharmaceuticals australia pty ltd - valsartan, quantity: 25.7 mg; sacubitril, quantity: 24.3 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; crospovidone; iron oxide red; titanium dioxide; macrogol 4000; hypromellose; hyprolose; magnesium stearate; microcrystalline cellulose; iron oxide black; purified talc - entresto is indicated in adult patients for the treatment of chronic heart failure (nyha class ii-iv) with reduced ejection fraction.

Entresto 25.7 mg, 24.3 mg Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

entresto 25.7 mg, 24.3 mg

شركة مستودع الأدوية الأردني - the jordan drugstore co - valsartan 25.7 mg, sacubitril 24.3 mg - 25.7 mg, 24.3 mg

CROSPOVIDONE Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

crospovidone

mavlab pty. ltd. - crospovidone - unknown - crospovidone ungrouped active 0.0 - active constituent